Increlex shortage

29 Apr 2013

ESPE has been informed by Ipsen that there is going to be an interruption in the supply of Increlex (mecasermin). The European Medicines Agency has also asked that all clinicians overseeing treatment of patients be aware of this. Current information can be found on the EMA website. We hope for an update in due course.